Skip to main content

Clinical and Dermoscopic Triage of head and neck Macules: The Role of Reflectance Confocal Microscopy in a Prospective Study of 2006 Lesions.

Journal of the American Academy of Dermatology2026-07-24PubMed
Total: 77.0Rigor: 8Innovation: 7Journal: 8Clinical: 8

Summary

In a prospective multicenter cohort of 2006 head/neck macules, adding RCM to dermoscopic triage substantially increased sensitivity for lentigo maligna/lentigo maligna melanoma and improved specificity, with only 0.4% malignancies detected during follow-up among initially managed-as-benign lesions. The combined approach reduces unnecessary biopsies and missed malignancies in cosmetically sensitive areas.

Key Findings

  • RCM plus dermoscopy led to 236/2006 (11.8%) lesions managed as malignant; histology confirmed 114 malignancies (62 LM/LMM; 52 BCC/SCC).
  • Sensitivity: dermoscopy detected 54.8% of LM/LMM vs RCM 91.9%; for BCC/SCC, dermoscopy 90.4% vs RCM 94.2%.
  • Only 0.4% (4/1000+) malignancies emerged during follow-up among initially non-malignant–managed lesions, indicating a safe noninvasive pathway.

Clinical Implications

Adopting RCM alongside dermoscopy can reduce unnecessary biopsies and enable noninvasive treatment of select lesions while maintaining high sensitivity for LM/LMM. Clinics should develop triage algorithms, training, and access pathways for RCM in cosmetically sensitive regions.

Why It Matters

This large, prospective diagnostic study demonstrates that RCM meaningfully augments dermoscopic triage, directly informing safer, less invasive management of equivocal macules on the face and neck.

Limitations

  • Verification/selection bias possible as not all lesions underwent histology; some losses to follow-up.
  • Generalizability may vary with operator expertise and device availability.

Future Directions

Assess cost-effectiveness, training curricula, and standardized RCM criteria; evaluate real-world impact on biopsy rates, time-to-diagnosis, and patient-reported outcomes.

Study Information

Study Type
Cohort
Research Domain
Diagnosis
Evidence Level
II - Prospective multicenter diagnostic cohort with histopathology reference and follow-up
Study Design
OTHER